Timber Pharmaceuticals, Inc.
TMBR
TMBR was delisted on the 28th of November, 2023.
2 hedge funds and large institutions have $1.58M invested in Timber Pharmaceuticals, Inc. in 2015 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
+$985K |
| 2 |
GMCM
Gruber & McBaine Capital Management
San Francisco,
California
|
+$631K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RI
1
RTW Investments
New York
| $949K | +$985K | +25 | New |
|
|
GMCM
2
Gruber & McBaine Capital Management
San Francisco,
California
| $628K | +$631K | +16 | New |
|
3
UBS Group
Zurich,
Switzerland
| $3K | – | – | – |
|
TMBR Hedge Fund Activity: Q2 2015 in Review
2 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Timber Pharmaceuticals, Inc. (TMBR) for Q2 2015, worth a combined $1.58M.
Buyers outnumbered sellers: 2 funds opened new TMBR positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was RTW Investments, opening a new position worth an estimated $985K.
- 2 institutional investors held Timber Pharmaceuticals, Inc. (TMBR) as of Q2 2015, up from 0 in Q1 2015.
- Funds reported $1.58M of Timber Pharmaceuticals, Inc. stock for Q2 2015.
- 2 funds opened new Timber Pharmaceuticals, Inc. positions in Q2 2015 and 0 closed out, a net change of +2 holders.
- The largest Timber Pharmaceuticals, Inc. buyer in Q2 2015 was RTW Investments, an estimated $985K added.
Based on aggregated 13F filings for Q2 2015.